Genentech, Inc.Usage: Phesgo (pertuzumab, trastuzumab, hyaluronidase) treats HER2-positive breast cancer in adults: neoadjuvant and adjuvant treatment with chemotherapy for early-stage breast cancer, and with docetaxel for metastatic breast cancer in patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.